Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Volume 32(2);  2024 Jun 20

Original Articles

Conditionally replicative adenovirus as a therapy for malignant peripheral nerve sheath tumors
Julia A. Nikrad, Robert T. Galvin, Mackenzie M. Sheehy, Ethan L. Novacek, Kari L. Jacobsen, Stanislas M.A.S. Corbière, Pauline J. Beckmann, Tyler A. Jubenville, Masato Yamamoto, David A. Largaespada
Mol Ther Oncol. 2024 Jun 20; 32(2): 200783. Published online 2024 Feb 28. doi: 10.1016/j.omton.2024.200783
PMCID:
PMC10959710
Article PDF–5.3M
A novel prognostic risk-scoring system based on m5C methylation regulator-mediated patterns for glioma patients
Yutong Wen, Xiaotong Chen, Runtong Li, Haiting Xie, Shuai Zhi, Kaitao Wang, Shang Yi, Wen Liang, Haiyan Hu, Shitao Rao, Xiaoya Gao
Mol Ther Oncol. 2024 Jun 20; 32(2): 200790. Published online 2024 Mar 5. doi: 10.1016/j.omton.2024.200790
PMCID:
PMC10965830
Article PDF–4.9M
CAR’TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment
Karin Teppert, Isabella Elias Yonezawa Ogusuku, Caroline Brandes, Vera Herbel, Nora Winter, Niels Werchau, Svetlana Khorkova, Christian Wöhle, Nojan Jelveh, Kevin Bisdorf, Boris Engels, Thomas Schaser, Kathleen Anders, Annette Künkele, Dominik Lock
Mol Ther Oncol. 2024 Jun 20; 32(2): 200797. Published online 2024 Mar 22. doi: 10.1016/j.omton.2024.200797
PMCID:
PMC11004219
Article PDF–4.5M
Enhanced therapeutic efficacy for glioblastoma immunotherapy with an oncolytic herpes simplex virus armed with anti-PD-1 antibody and IL-12
Lei Wang, Xusha Zhou, Xiaoqing Chen, Yuanyuan Liu, Yue Huang, Yuan Cheng, Peigen Ren, Jing Zhao, Grace Guoying Zhou
Mol Ther Oncol. 2024 Jun 20; 32(2): 200799. Published online 2024 Apr 6. doi: 10.1016/j.omton.2024.200799
PMCID:
PMC11053222
Article PDF–2.6M
Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulation
Catrin Heim, Leonie Hartig, Nadine Weinelt, Laura M. Moser, Emilia Salzmann-Manrique, Michael Merker, Winfried S. Wels, Torsten Tonn, Peter Bader, Jan-Henning Klusmann, Sjoerd J.L. van Wijk, Eva Rettinger
Mol Ther Oncol. 2024 Jun 20; 32(2): 200802. Published online 2024 Apr 11. doi: 10.1016/j.omton.2024.200802
PMCID:
PMC11067460
Article PDF–3.1M
Induction of necroptosis in multinucleated giant cells induced by conditionally replicating syncytial oHSV in co-cultures of cancer cells and non-cancerous cells
Takuma Suzuki, Hiroaki Uchida
Mol Ther Oncol. 2024 Jun 20; 32(2): 200803. Published online 2024 Apr 15. doi: 10.1016/j.omton.2024.200803
PMCID:
PMC11067338
Article PDF–2.2M
The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles
Konstantinos Vazaios, Εftychia Stavrakaki, Lisette B. Vogelezang, Jie Ju, Piotr Waranecki, Dennis S. Metselaar, Michaël H. Meel, Vera Kemp, Bernadette G. van den Hoogen, Rob C. Hoeben, E. Antonio Chiocca, William F. Goins, Andrew Stubbs, Yunlei Li, Marta M. Alonso, Friso G. Calkoen, Esther Hulleman, Jasper van der Lugt, Martine L.M. Lamfers
Mol Ther Oncol. 2024 Jun 20; 32(2): 200804. Published online 2024 Apr 15. doi: 10.1016/j.omton.2024.200804
PMCID:
PMC11060958
Article PDF–4.7M

Reviews

The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy
Anup S. Pathania, Haritha Chava, Ramesh Balusu, Anil K. Pasupulati, Don W. Coulter, Kishore B. Challagundla
Mol Ther Oncol. 2024 Jun 20; 32(2): 200785. Published online 2024 Feb 29. doi: 10.1016/j.omton.2024.200785
PMCID:
PMC10973673
Article PDF–2.5M
Harnessing exosomes as a platform for drug delivery in breast cancer: A systematic review for in vivo and in vitro studies
Abdulwahab Teflischi Gharavi, Saeed Irian, Azadeh Niknejad, Keykavous Parang, Mona Salimi
Mol Ther Oncol. 2024 Jun 20; 32(2): 200800. Published online 2024 Apr 6. doi: 10.1016/j.omton.2024.200800
PMCID:
PMC11067457
Article PDF–3.3M

Corrections

Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment
Francisca Cristi, Maiah Walters, Nashae Narayan, Kate Agopsowicz, Mary M. Hitt, Maya Shmulevitz
Mol Ther Oncol. 2024 Jun 20; 32(2): 200798. Published online 2024 Apr 4. doi: 10.1016/j.omton.2024.200798
Corrects:
Mol Ther Oncolytics. 2023 Dec 19; 31: 100743.
PMCID:
PMC11000176
Correction PDF–2.0M
Gut microbiota composition is associated with the efficacy of Delta-24-RGDOX in malignant gliomas
Natalie M. Meléndez-Vázquez, Teresa T. Nguyen, Xuejun Fan, Andrés R. López-Rivas, Juan Fueyo, Candelaria Gomez-Manzano, Filipa Godoy-Vitorino
Mol Ther Oncol. 2024 Jun 20; 32(2): 200801. Published online 2024 Apr 17. doi: 10.1016/j.omton.2024.200801
Corrects:
Mol Ther Oncol. 2024 Mar 21; 32(1): 200787.
PMCID:
PMC11047782
Correction PDF–209K
Articles from Molecular Therapy Oncology are provided here courtesy of American Society of Gene & Cell Therapy